Skip to content
Clinical Trial Events
SCOPE Summit for Clinical Ops Executives

Panel Digital Health Technologies track

Unlocking New Frontiers in Alzheimer’s Disease Research through Digital Measures

Thu, Feb 6, 2025 · 10:40–11:10 AM EST Rosen Shingle Creek

About this session

Panel Discussion.

Imagine a world where the relentless progression of Alzheimer's disease and related dementias (ADRD) could be detected earlier, monitored more precisely, and treated more effectively—all through the power of digital health technologies. In this session, we will share some of the exciting findings from a recent DiMe pre-competitive collaboration, involving experts from academia, industry, clinical practice, and patient advocacy groups, to support leaders engaging in ADRD research to harness the power of digital innovation to accelerate scientific progress and improve outcomes for patients and caregivers impacted by ADRD.

Speakers

  • Sarah Valentine

    Partnerships Lead - Life Sciences · Digital Medicine Society (DiMe)

    Moderator

  • Ann M. Hake

    Executive Director · Eli Lilly & Co

    Panelist

  • Jeffrey A. Kaye

    Director · Oregon Health & Science University

    Panelist

  • Mark Matson

    Sr Director · Medidata Solutions

    Panelist